TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia
- 19 November 2003
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 38 (4) , 201-208
Abstract
Different mechanisms, such as chromosomal rearrangements, deletions, mutations, and methylation/demethylation of the promoter regions of genes, have been shown to be involved in acute lymphoblastic leukaemia (ALL). These genetic and epigenetic alterations lead to the activation of protooncogenes or to inactivation of tumour supressor genes promoting cell proliferation. One of the most frequently inactivated tumour supressor genes is TP53, which is altered in 50% of human tumours. In this study, we have analysed: (1) the complete coding region, all intron‐exon junctions and noncoding regions of exons 1–11 of TP53 by lexon‐DGGE; (2) the methylation status of the 5′ region of TP53 and (3) the deletion of one or both alleles of the gene by fluorescence in situ hybridisation (FISH) in 57 ALL patients. Using these techniques, we have found promoter methylation in 32% of the cases, missense mutations in 8.8%, and deletion of one allele in 7.5% of the samples, with TP53 being altered in 40% of the ALL samples studied in this series.Keywords
This publication has 33 references indexed in Scilit:
- The codon 72 polymorphic variants of p53 have markedly different apoptotic potentialNature Genetics, 2003
- Cellular senescence and cancerThe Journal of Pathology, 1999
- DNA damage activates p53 through a phosphorylation–acetylation cascadeGenes & Development, 1998
- Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formationThe EMBO Journal, 1998
- Exons – Introns = Lexons: In-frame concatenation of exons by PCRHuman Mutation, 1998
- THE CLINICAL SIGNIFICANCE OF MUTATIONS OF THE P52 TUMOUR SUPPRESSOR GENE IN HAEMATOLOGICAL MALIGNANCIESBritish Journal of Haematology, 1997
- CpG Methylation Inactivates the Transcriptional Activity of the Promoter of the Humanp53Tumor Suppressor GeneBiochemical and Biophysical Research Communications, 1997
- P53 and angiogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Exhaustive analysis of the P53 gene coding sequence by denaturing gradient gel electrophoresis: Application to the detection of point mutations in acute leukemiasHuman Mutation, 1994
- TP53 tumor suppressor gene: A model for investigating human mutagenesisGenes, Chromosomes and Cancer, 1992